BioSpace News Archive

Today, Patientory Inc. and UK-based IrisGuard announced a collaboration to combine leading iris biometric technology and healthcare focused PTOYNet blockchain network for enhanced security measures.

ThermoGenesis Corp., a private corporation owned by Cesca Therapeutics (Nasdaq: KOOL), has entered into a Supply Agreement with Orthohealing Center Management (OCM) that will allow the OCM network of physicians to utilize the ThermoGenesis PXP system to prepare a precise cell concentrate from autologous bone marrow in their office laboratories in order to provide the benefits of their Orthohealing Method to their patients.

Maryland-based urgent care company Righttime Medical Care has opened its newest Care Center in Bethesda at 4507 Stanford Street.

The organizers are pleased to announce the 1st Edition of Sweet Pharma Day on April 23rd, 2019, the day before the Effervescence Conference.

Leap Therapeutics, Inc. announced the pricing of an underwritten public offering of 6,571,428 shares of its common stock and warrants to purchase up to 6,571,428 shares of its common stock.

Kali-Extracts, Inc. announced a preview presentation scheduled for next week, on Tuesday, February 5th, to be published on line by KALY CEO Fred Ferri with Professor Jeffry Osbourn, Ph.D., from the University of Kentucky.

First patient enrolled in StimLabs Revita Efficacy Trial for Diabetic Foot Ulcers

New Orders, Production, and Employment Growing; Supplier Deliveries Slowing at Slower Rate; Backlog Growing; Raw Materials Inventories Growing; Customers’ Inventories Too Low; Prices Decreasing; Exports and Imports Growing

Q BioMed Inc. announced the Company’s CEO Denis Corin will deliver a corporate presentation and conduct one-on-one meetings with investors and potential business partners at the BIO CEO & Investor Conference on February 11th -12th, 2019 in New York City.

Team Gleason is proud to add another powerful option to its toolkit of technology solutions for people living with ALS.